Change of Circulating Tumor Cells During Laparoscopic or Transanal Endoscopic Surgery for Rectal … (NCT05109130) | Clinical Trial Compass
UnknownNot Applicable
Change of Circulating Tumor Cells During Laparoscopic or Transanal Endoscopic Surgery for Rectal Cancer.
China100 participantsStarted 2021-10-18
Plain-language summary
The primary purpose of this study is to compare the changes of circulating tumor cells (CTCs) at different time points in rectal cancer patients undergoing laparoscopic or transanal endoscopic radical resection. Our secondary purpose is to explore the effects of perioperative circulating tumor cells on tumor recurrence and metastasis.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Mid-low rectal cancer.
. Single lesion.
. No metastasis.
. Clinical Stage T2-3, N0-1.
Exclusion criteria
. History of malignant tumors.
. Acute bowel obstruction, bleeding or perforation.
. Received neoadjuvant treatment.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is comparing laparoscopic surgery to transanal endoscopic surgery for rectal cancer — which of those two surgical approaches does my care team currently think is the better fit for my specific tumor, and why?
2The trial is measuring whether circulating tumor cells in the bloodstream change during surgery, which could relate to the risk of cancer spreading — what does my doctor think the current evidence says about whether one surgical method is safer in that regard?
3Since the recruitment status for this trial is listed as unknown, is this study actually still enrolling patients, and would participating change anything about the type of surgery or monitoring I'd receive compared to standard care?
4This study is categorized as Phase NA, meaning it's more of an observational or exploratory study rather than a treatment trial — does joining it affect my treatment decisions at all, or would I be receiving the same surgery regardless?
5If circulating tumor cells are being tracked as part of this trial, would those results be shared with me and my care team in a way that could influence my follow-up care or surveillance plan after surgery?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change of circulating tumor cells during laparoscopic or transanal endoscopic surgery